Moscow [Russia], August 23 (ANI): Russia's Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announced the development of the Sputnik V vaccine specifically adapted against Delta and Omicron variants of coronavirus.
New Delhi [India], July 14 (ANI): The Union Health Secretary Rajesh Bhushan has written a letter to all the states and union territories' chief secretaries and administrators over the precaution dose for COVID-19 vaccine Sputnik V.
Moscow [Russia], May 24 (ANI): Gamaleya National Research Center of Epidemiology and Microbiology on Wednesday said that Sputnik V demonstrated strong protection against Omicron variant of COVID-19.
Moscow [Russia], May 9 (ANI/Sputnik): Russian Health Minister Mikhail Murashko said on Monday that consultations with the World Health Organization (WHO) on approval of the Russian Sputnik V COVID-19 vaccine are still underway.
New Delhi [India], May 3 (ANI): The Supreme Court has asked the Ministry of Health and Family Welfare Ministry to decide on a representation of a person seeking modification of COVID-19 policy to allow voluntary re-vaccination of persons who have received the Sputnik-V vaccine and are desiro
New Delhi [India], April 30 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) recommended that the Russian COVID-19 vaccine Sputnik Light which contains the same ingredients as the first dose of Sputnik V can be taken as a precaution dose, said Sources.
Moscow [Russia], April 2 (ANI): Russian Health Ministry has registered the nasal version of Sputnik V, the world's first nasal vaccine against COVID-19.
New Delhi [India], January 20 (ANI): Russia's COVID-19 vaccine Sputnik V has demonstrated strong protection against the Omicron variant of the virus compared to the Pfizer vaccine, according to a study conducted at the Spallanzani Institute in Italy in collaboration with investors in the Spu
Moscow [Russia], January 18 (ANI/Sputnik): The effectiveness of the Sputnik V COVID-19 vaccine against the Omicron coronavirus variant is 75 per cent, Alexander Gintsburg, the head of Russia's Gamaleya Research Center, said on Tuesday.
Canberra [Australia], January 17 (ANI/Sputnik): Australia's Therapeutic Goods Administration (TGA) has recognized the two-dose course of the Russian Sputnik V vaccine against COVID-19 as an acceptable form of coronavirus vaccination for travellers.
Moscow [Russia], January 12 (ANI): Sputnik V demonstrates very high efficacy against Omicron variant and appears to be more effective than other vaccines against the new strain, said Russian President Vladimir Putin said on Wednesday.
Moscow [Russia], December 22 (ANI): Sputnik V demonstrates high virus-neutralizing activity against Omicron variant, according to a study by Gamaleya Center's preliminary laboratory.